A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker's key HIV business.

https://ift.tt/2KUv8fF support@endlesssupplies.biz (Endless Supplies .Biz) August 15, 2018 at 01:51AM
No comments:
Post a Comment